103
|
Lopes J, Debrauwère H, Buard J, Nicolas A. Instability of the human minisatellite CEB1 in rad27Delta and dna2-1 replication-deficient yeast cells. EMBO J 2002; 21:3201-11. [PMID: 12065432 PMCID: PMC125388 DOI: 10.1093/emboj/cdf310] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Convergent studies in human and yeast model systems have shown that some minisatellite loci are relatively stable in somatic cells but not in the germline, and little is known about the mechanism(s) that can destabilize them. Unlike microsatellite sequences, mini satellites are not destabilized by mismatch repair mutations. We report here that the absence of Rad27 and Dna2 functions but not RNase H(35) or Exo1, which play an essential role in the processing of Okazaki fragments during replication, destabilize the human minisatellite CEB1 in mitotically growing Saccharomyces cerevisiae cells, up to 14% per generation in rad27Delta cells. Analysis using minisatellite variant repeat mapping by polymerase chain reaction of the internal structure of 17 variants reveals that the majority of rearrangements in rad27Delta cells are extremely complex contraction events that contain deletions, often accompanied by duplications of motif unit. Altogether, these results suggest that the improperly processed 5' flap structures that accumulate when replication is impaired can act as a potent stimulator of minisatellite destabilization and can provoke an unexpectedly broad range of mutagenic events. This replication-dependent phenomenon differs from the recombination-induced instability in yeast meiotic cells.
Collapse
Affiliation(s)
- Judith Lopes
- Institut Curie, Section de Recherche, CNRS UMR144, 26 rue d’Ulm, 75248 Paris Cedex 05 and Institut de Génétique Humaine, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France Present address: Chromosome Replication Laboratory, Clare Hall Laboratories, Cancer Research UK, Blanche Lane, South Mimms, Herts EN6 3LD, UK Corresponding author e-mail: J.Lopes and H.Debrauwère contributed equally to this work
| | - Hélène Debrauwère
- Institut Curie, Section de Recherche, CNRS UMR144, 26 rue d’Ulm, 75248 Paris Cedex 05 and Institut de Génétique Humaine, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France Present address: Chromosome Replication Laboratory, Clare Hall Laboratories, Cancer Research UK, Blanche Lane, South Mimms, Herts EN6 3LD, UK Corresponding author e-mail: J.Lopes and H.Debrauwère contributed equally to this work
| | - Jérôme Buard
- Institut Curie, Section de Recherche, CNRS UMR144, 26 rue d’Ulm, 75248 Paris Cedex 05 and Institut de Génétique Humaine, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France Present address: Chromosome Replication Laboratory, Clare Hall Laboratories, Cancer Research UK, Blanche Lane, South Mimms, Herts EN6 3LD, UK Corresponding author e-mail: J.Lopes and H.Debrauwère contributed equally to this work
| | - Alain Nicolas
- Institut Curie, Section de Recherche, CNRS UMR144, 26 rue d’Ulm, 75248 Paris Cedex 05 and Institut de Génétique Humaine, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France Present address: Chromosome Replication Laboratory, Clare Hall Laboratories, Cancer Research UK, Blanche Lane, South Mimms, Herts EN6 3LD, UK Corresponding author e-mail: J.Lopes and H.Debrauwère contributed equally to this work
| |
Collapse
|
111
|
Herman-Bert A, Stevanin G, Netter JC, Rascol O, Brassat D, Calvas P, Camuzat A, Yuan QP, Schalling M, Dürr A, Brice A. Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet 2000; 67:229-35. [PMID: 10820125 PMCID: PMC1287081 DOI: 10.1086/302958] [Citation(s) in RCA: 115] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2000] [Accepted: 03/12/2000] [Indexed: 11/03/2022] Open
Abstract
We examined a large French family with autosomal dominant cerebellar ataxia (ADCA) that was excluded from all previously identified spinocerebellar ataxia genes and loci. The patients-seven women and a 4-year-old boy-exhibited slowly progressive childhood-onset cerebellar gait ataxia associated with cerebellar dysarthria, moderate mental retardation (IQ 62-76), and mild developmental delays in motor acquisition. Nystagmus and pyramidal signs were also observed in some cases. This unique association of clinical features clearly distinguishes this new entity from other previously described ADCA. Cerebral magnetic-resonance imaging showed moderate cerebellar and pontine atrophy in two patients. We performed a genomewide search and found significant evidence for linkage to chromosome 19q13.3-q13.4, in an approximately 8-cM interval between markers D19S219 and D19S553.
Collapse
Affiliation(s)
- Alexandra Herman-Bert
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Giovanni Stevanin
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Jean-Claude Netter
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Olivier Rascol
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - David Brassat
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Patrick Calvas
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Agnès Camuzat
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Qiu-ping Yuan
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Martin Schalling
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Alexandra Dürr
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| | - Alexis Brice
- INSERM U289, Hôpital de la Salpêtrière, and Consultation de Génétique Médicale, Hôpital de la Salpêtrière, Paris; Service de Néonatologie, Centre Hospitalier Intercommunal de Tarbes, Tarbes, France; Service de Pharmacologie Clinique, Faculté de Médecine, Fédération de Neurologie, Hôpital Purpan, and Consultation de Génétique Médicale, Hôpital Purpan, Toulouse, France; and Neurogenetics Unit, Department of Molecular Medicine, Karolinska Hospital, Stockholm
| |
Collapse
|